10.30 am Melbourne time.
LBS.06 - Late Breaking Science in Coronary RevascularizationWhen: Sunday, November 11, 2018, 5:30 p.m.– 6:45 p.m.
Where: Main Event II (s100)
- REGROUP
Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial With Long-Term Follow-up
- FREEDOM Follow-On Study
Long-term Survival following Multivessel Revascularization in Patients with Diabetes: the FREEDOM Follow-On Study
- TiCAB
A Randomized, Double-blind Study Of Ticagrelor Versus Aspirin In Patients Undergoing Coronary Bypass Surgery
- ISAR TEST 4
Ten-Year Clinical Outcomes After Coronary Drug-Eluting Stents with Biodegradable or Permanent Polymer Coating: Results from the Randomized ISAR-TEST 4 Trial
- Intramyocardial Injection of Mesenchymal Precursor Cells in Left Ventricular Assist Device Recipients: Impact on Myocardial Recovery and Morbidity
- Forums
- ASX - By Stock
- AHA conference details
10.30 am Melbourne time. LBS.06 - Late Breaking Science in...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 0.935 |
12 | 175098 | 0.930 |
7 | 101559 | 0.925 |
8 | 126323 | 0.920 |
10 | 99179 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 14089 | 2 |
0.950 | 32015 | 3 |
0.955 | 49989 | 4 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online